Abstract Submission Guidelines
The abstract submission deadline was March 15, 2022, 11:59PM CST.
An individual may be the first author on a maximum of three (3) abstracts.
An individual may be a contributing author on an unlimited number of abstracts.
All submitted abstracts become the property of MDS.
Format
Text limit of 2,500 characters (including spaces). The size limit includes characters and spaces in the Abstract Title and Abstract Body. Please note that spaces are included in the overall character count. The size limit does not include author information.
Abstracts should be arranged as follows:
- Objective
- Background
- Methods
- Results
- Conclusions
*You may submit a case report using the standard abstract format
Do not include any identifying information directly on the abstract.
Only non-proprietary (generic) drug names should be used and should be written without capitals.
Do not include branded product names in the abstract. If the abstract is found to contain marketing, rather than scientific content, the abstract will be rejected.
Select one (1) category under which the abstract should be reviewed. If the abstract covers more than one topic, please choose the most appropriate category and indicate additional related topics via corresponding keywords. This will aid online searches and further organization of your abstract within the listed category (see “Review and Categorization” regarding re-categorizing a submitted abstract).
The use of standard abbreviations is desirable. A special or unusual abbreviation should be placed in parentheses after the first appearance of the full word for which it stands.
Please note there is a separate upload field for tables and graphs. To include tables or figures, enter the appropriate ID tag within the abstract body where the tables and/or figures should appear. Tags must be entered as shown - [table1] for your first table; [table2] for your second table; [figure1] for your first figure; [figure2] for your second figure.
To list references, enter the appropriate ID tag. [1] for your first reference, [2] for your second reference, [3] for your third reference, etc.
Submission and Eligibility
Abstract submissions are now closed.
The sole means of submission is via the Internet. Please do not e-mail, fax, or mail abstract submissions.
Abstracts must be submitted and presented in English.
MDS members and non-members are eligible to submit abstracts.
There is no fee for submitting an MDS abstract.
MDS does not offer CME credit for poster viewing or submitted abstracts.
MDS International Congress faculty are not required to submit an abstract.
All accepted abstracts will be published and included on the Congress virtual platform, regardless of in-person attendance status at the 2022 International Congress in Madrid. However, MDS strongly recommends attending in-person for the exceptional networking and collaboration opportunities. If accepted, all abstract presenters are responsible for their own registration and other fees associated with attending the International Congress.
Previously Published Abstracts and Plagiarism
All submitted abstracts will be run through an online plagiarism detection software. Should plagiarism be detected, the abstract will be rejected.
Abstracts that have been presented at other meetings may be submitted if they have not been previously published. Submitted abstracts that have been presented at other meetings must include the previous meeting name and presentation date cited accordingly in the abstract body, after the Conclusion.
If the abstract is found to have been previously published in another MDS publication or a previous edition of the Movement Disorders journal, the designated contact person will be notified and required to revise the abstract, or the abstract will be rejected.
All abstracts presented at a previous MDS International Congress have been published by MDS.
MDS does not republish previously published International Congress abstracts.
Review and Categorization
The MDS Congress Scientific Program Committee will review all abstracts in March of 2022. The Committee shall be directed to reject abstracts for the following reasons:
- Plagiarism detected
- Marketing detected
- Subject not related to the field of Movement Disorders
- Does not meet basic requirements
All submitted abstracts will be run through an online plagiarism detection software. Should plagiarism be detected, the abstract will be rejected.
If it is determined by the Congress Scientific Program Committee that a submitted abstract is not entered in the optimal abstract category listing, MDS reserves the right to re-categorize the abstract on behalf of the author(s) without prior notification. The new category placement will be confirmed in the official abstract notification letter.
If it is determined that the abstract should be re-categorized, MDS will ensure that the new category placement is in the best interest of the work and easily searchable by International Congress attendees as well as online researchers.
Notification and Correspondence
All notifications regarding a saved or submitted abstract will be sent only to the person identified as ‘Contact for Official Abstract Correspondence’. It is expected that the designated contact person will circulate updates regarding the abstract as needed.
All successfully submitted abstracts will receive a confirmation e-mail to the designated contact person. If the confirmation e-mail has not been received within 24-hours of submitting the abstract, please log in to the abstract submission site to verify the status of the submission.
Abstract acceptance notifications will be sent to the designated contact person via e-mail in June 2022. An official abstract notification letter will be available through the submission site and can be downloaded and printed at any time after notifications have been sent in June 2022.
All confirmed abstract submissions will be reviewed for acceptance by MDS.
Abstracts with a status of ‘saved’ are not confirmed submissions and will not be reviewed by MDS.
Please ensure that Omnipress is designated as a “safe sender” to ensure timely correspondence regarding the abstract submission.
Please check your spam and junk e-mail folders before contacting MDS regarding the status of your abstract. Abstract notices will come from Omnipress. Abstract status can also be checked directly on the submission site in June 2022.
Withdrawing a Submitted Abstract
March 15 – July 15, 2022
Requests to withdraw a submitted abstract after the submission deadline (March 15, 2022) must be received in writing by July 15, 2022 to congress@movementdisorders.org.
July 16, 2022 – Onward
After July 16, 2022, your abstract cannot be withdrawn and will remain a part of the 2022 MDS published abstracts. All submitted abstracts become the property of MDS.
Publication of Accepted Abstracts
All accepted abstracts will be published in an electronic supplement to the Movement Disorders journal online edition. All submitted abstracts become the property of MDS.
MDS only accepts original work. By submitting your abstract, you affirm that your abstract is your own, either individually or as a group. Should plagiarism be detected, the abstract will be rejected.
IMPORTANT: Abstract data and content can NOT be updated after it has been accepted (notifications will be sent in June 2022). Submissions must include all data as it will be published, without need for updating after submission. Please review all content prior to submitting; including author listing and spelling.
If the abstract data will not be available until after the submission deadline, then it is recommended to submit as a Late-Breaking Abstract (opening in June 2022).
Abstract Presentation
Abstract presenters have several options and can choose any or all of the following presentation formats. To provide the best user experience possible, all accepted abstract presenters are encouraged to participate in all virtual and in-person presentation options:
- Present an accepted abstract as an e-poster in Madrid during scheduled poster sessions
- High-ranking abstracts may also be selected for additional oral platform presentation
- Present as a 5-minute pre-recorded video (oral) presentation on the MDS Congress virtual platform
- Present as an e-poster on the MDS Congress virtual platform
Poster specifications and details will be provided with the acceptance notification letter in June. Presenters that want to begin preparations can anticipate that e-posters will be a one-page PDF file not to exceed 150 MB in horizontal orientation (to best fit the monitor screen). Video presentations for the virtual platform must be in MP4 format, and not to excel 150 MB file size. Video presentation must not exceed 5 minutes duration. E-poster and video presentations will be collected in June 2022, after abstract acceptance notifications have been sent.
MDS strongly encourages all abstract presenters to participate in all presentation formats. Accepted abstract presenters should plan to attend the Congress to present the poster during the scheduled poster session(s). Attendance is not mandatory, and does not affect abstract acceptance or publication.